苏州大学医学部药学院
教案
课程名称: | Pharmacology IV |
授课对象: | 2018级药学英文班 |
授课学时: | 72 h |
教材版本: | 《Basic and Clinical Pharmacology》,14th Edition |
主讲教师: | Zhen Xuechu, Zhang Huiling, et al. |
苏州大学医学部药学院制
2020年08月07日
授课教师:秦正红授课日期:2020.09.08
授课教师:秦正红授课日期:2020.09.09
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic & Clinical Pharmacology, 14th edition | 授课年级 | 2018级药学英文班 |
授课章节 | Chapter 2 Drug Receptors & Pharmacodynamics | 授课时间 | 150分钟 |
| |||
(1) To learn the types and definition of therapeutical effects and adverse reactions. (2) To learn the definition and the significance of dose-effect relationship. (3) To learn the basic concepts of receptor kinetics, the types of receptors, the second messengers, and the significance of receptor regulation. (4) To learn the definition of pharmacodynamics. (5) To understand the mechanisms of drugs’ action.
| |||
| |||
1. The specificity and selectivity of drugs’ action; pharmacological effects, excitation and inhibition; therapeutic effects of drugs, etiological treatments and symptomatic treatments; adverse reactions, side reactions, toxic effects, withdrawal effects and allergic reactions. [20 min] 2. Dose-effect relationship and dose-effect curve, efficacy, median lethal dose (LD50), potency, therapeutic index, margin of safety. [20 min] 3. The mechanisms of actions of drugs. [10 min] 4. Receptor and drug: the definition and feature of receptor, significance of receptor on drug action, the definition of ligand, agonist, partial agonist, antagonist; the definition and characteristics of competitive antagonist and non-competitive antagonist; affinity, intrinsic activity, the types of receptors, the definition and types of the second messengers, receptor desensitization. [15 min] 5. The adverse reactions. [15 min] 6. Dose-effect relationship and dose-effect curve. [10 min] 7. EC50, threshold dose, potency, maximal effect (Emax) [20 min] 8. Median effect dose (ED50), median lethal dose (LD50), therapeutic index (TI), margin of safety or CSF (certain safety factor). [10 min] 9. Introduction to receptor: The concepts and the classification of receptors. [10 min] 10. G-protein-coupled receptors, transmembrane kinase receptors, ligand gated ion channel receptors, and intracellular receptors. [20 min] | |||
三、教学重点与难点 | |||
1.教学重点 The specificity and selectivity of drugs’ action; pharmacological effects, excitation and inhibition; therapeutic effects of drugs, etiological treatments and symptomatic treatments; adverse reactions, side reactions, toxic effects, withdrawal effects and allergic reactions. Receptor and drug: the definition and feature of receptor, significance of receptor on drug action, the definition of ligand, agonist, partial agonist, antagonist; the definition and characteristics of competitive antagonist and non-competitive antagonist; affinity, intrinsic activity, the types of receptors, the definition and types of the second messengers, receptor desensitization. 2.教学难点 G-protein-coupled receptors, transmembrane kinase receptors, ligand gated ion channel receptors, and intracellular receptors | |||
四、教学方法选择 | |||
1. 理论课堂教学 A. 多媒体教学:(简要列出本章节多媒体教学设计特点及优势) By using multimedia including PPT, cartoon, video in the teaching learning process, we convey vast information and provide many sources from which student can access the information. The Multimedia approach may improve the teaching learning process, provide the opportunity for the students to gain mastery of competencies and skills, and enable the students to get access to information in dynamic environment. B. 互动教学:(根据实际情况列出案例/实例讨论、分析讨论、分组讨论、翻转课堂等互动教学内容标题) 1. The significance of the EC50/ED50. 2. For an optimal choice of a drug, either potency or Emax is crucial? 2. 实验教学:(简要列出实验内容标题) | |||
五、更新或补充内容提要 | |||
六、复习思考题 | |||
1. The significance of the EC50/ED50. 2. For an optimal choice of a drug, either potency or Emax is crucial? | |||
七、学习资源、课外自主学习参考 | |||
(可以列出供学生进一步学习、拓展本章节内容的网站、著作、期刊的名称及内容等) 朱依谆主编. 药理学第八版, 北京, 人民卫生出版社, 2019 Oxford Textbook of Clinical Pharmacology and Drug Therapy David Grahame-Smith , Jeffrey Aronson. Edition: 3 Clinical Pharmacology Made Incredibly Easy! (Incredibly Easy! Series) Springhouse , 2008 Edition: 3Rev Ed. |
苏州大学医学部药学院授课教案
授课教师:秦正红授课日期:2020.09.11
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic & Clinical Pharmacology, 14th edition | 授课年级 | 2018级药学英文班 |
授课章节 | Chapter 3 Pharmacokinetics & Pharmacodynamics | 授课时间 | 100分钟 |
| |||
(1) The ADME process of drug.(2) The characteristic of simple diffusion.(3) First pass elimination.(4) The process of absorption.(5) The significance of plasma protein binding.(6) Two kinds of physiological barrier.(7) The three patterns of renal excretion.(8) The definition of hepato-enteral circulation.(9) How does the pH of body fluid & ionization of drugs affect the distribution of drug.(10) The action, site and steps of drug metabolism.(11) The definition of Tmax, Cmax, Vd, CL and the calculation methods of t1/2, AUC, F.(12) How to use the index (Tmax, Cmax, AUC, F) to evaluate the quantity of the drug.(13) Etiological therapy and Symptomatic therapy.(14) The division of compartment models.2. 技能(能力)目标: | |||
| |||
1. The objectives and contents of pharmacokinetics. [4 min] 2. The three patterns of drug transportation. [3 min] 3. Effect of pH on the rate of simple diffusion. [4 min] 4. The characteristics of filtration and carrier-mediated transport. [4 min] 5. GI administration includes oral administration, sublingual administration and rectal administration. [11 min] 6. The hepatic first-pass effect can be avoided by use of sublingual tablets, transdermal preparations, rectal suppositories and inhalation preparations. [4 min] 7. The route and the characteristics of injection, inhalation, transdermal administration, and local administration. [4 min] 8.The significance of plasma protein binding and physiological barriers. [7 min] 9. Basic concepts of pharmacokinetics and time-concentration curve. [10 min] 10. Pharmacokinetic parameters including Tmax, Cmax, apparent volume of distribution (Vd), elimination rate constant (k), half time (t1/2), area under the curve (AUC), bioavailability (F), and clearance (CL). [16 min] 12. Etiological therapy and symptomatic therapy. [10 min] | |||
| |||
The hepatic first-pass effect can be avoided by use of sublingual tablets, transdermal preparations, rectal suppositories and inhalation preparations.
Effect of pH on the rate of simple diffusion. | |||
| |||
A. 多媒体教学:(简要列出本章节多媒体教学设计特点及优势) By using multimedia including PPT, cartoon, video in the teaching learning process, we convey vast information and provide many sources from which student can access the information. The Multimedia approach may improve the teaching learning process, provide the opportunity for the students to gain mastery of competencies and skills, and enable the students to get access to information in dynamic environment. B. 互动教学:(根据实际情况列出案例/实例讨论、分析讨论、分组讨论、翻转课堂等互动教学内容标题) (1). According to Dm and DL, how to design the administration strategy? (2). The processes of drug metabolism.
| |||
| |||
| |||
1. What does first pass elimination mean? 2. According to the elimination kinetics of drugs, how to guide the rational administration? 3. How to use the index (Tmax, Cmax, AUC, F) to evaluate the quantity of the drugs? | |||
| |||
(可以列出供学生进一步学习、拓展本章节内容的网站、著作、期刊的名称及内容等) 朱依谆主编. 药理学第八版, 北京, 人民卫生出版社, 2019 Oxford Textbook of Clinical Pharmacology and Drug Therapy David Grahame-Smith , Jeffrey Aronson. Edition: 3 Clinical Pharmacology Made Incredibly Easy! (Incredibly Easy! Series) Springhouse , 2008 Edition: 3Rev Ed. |
苏州大学医学部药学院授课教案
授课教师:秦正红授课日期:2020.09.15
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic & Clinical Pharmacology, 14th edition | 授课年级 | 2018级药学英文班 |
授课章节 | Chapter 4 Drug Biotransformation | 授课时间 | 100分钟 |
| |||
(1) To learn the key procedures of drug biotransformation.(2) To learn the roles of biotransformation in drug disposition.(3) To learn the major organs where drug biotransformation occurs.(4) To understand the enzymes involved in biotransformation. 技能(能力)目标: | |||
| |||
1. The roles of biotransformation. [20 min] 2. Human Liver P450 Enzymes. [30 min] Induction & inhibition of P450.3. Toxicity of Acetaminophen. [30 min] | |||
三、教学重点与难点 | |||
1.教学重点 Human Liver P450 Enzymes 2.教学难点 Induction & inhibition of P450. | |||
四、教学方法选择 | |||
1. 理论课堂教学 A. 多媒体教学:(简要列出本章节多媒体教学设计特点及优势) By using multimedia including PPT, cartoon, video in the teaching learning process, we convey vast information and provide many sources from which student can access the information. The Multimedia approach may improve the teaching learning process, provide the opportunity for the students to gain mastery of competencies and skills, and enable the students to get access to information in dynamic environment. B. 互动教学:(根据实际情况列出案例/实例讨论、分析讨论、分组讨论、翻转课堂等互动教学内容标题) Why is biotransformation necessary for some drugs? Where does drug biotransformation occur? 2. 实验教学:(简要列出实验内容标题) | |||
五、更新或补充内容提要 | |||
六、复习思考题 | |||
What is the major roles of biotransformation? What are the enzymes involved in biotransformation? | |||
七、学习资源、课外自主学习参考 | |||
(可以列出供学生进一步学习、拓展本章节内容的网站、著作、期刊的名称及内容等) 朱依谆主编. 药理学第八版, 北京, 人民卫生出版社, 2019 Oxford Textbook of Clinical Pharmacology and Drug Therapy David Grahame-Smith , Jeffrey Aronson. Edition: 3 Clinical Pharmacology Made Incredibly Easy! (Incredibly Easy! Series) Springhouse , 2008 Edition: 3Rev Ed. |
苏州大学医学部药学院授课教案
授课教师:秦正红授课日期:2020.09.16
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic & Clinical Pharmacology, 14th edition | 授课年级 | 2018级药学英文班 |
授课章节 | Chapter 5 Development & Regulation of Drugs | 授课时间 | 100分钟 |
| |||
(1) To learn the variations in drug responsiveness.(2) To learn the mechanisms of receptor regulation.(3) To understand the factors of geriatric considerations.(4) To understand the selectivity of drugs. 2.技能(能力)目标: | |||
| |||
1. Variations in drug responsiveness: alteration in concentration of drug that reaches the receptor; variations in concentration of an endogenous receptor ligand; alterations in number or function of receptors; changes in components of response distal to the receptor. [10 min] 2. Receptor regulation: synthesis and degradation, covalent modification, association with other regulatory proteins, relocalization within the cell; be subject to feedback by their own signaling outputs. [10 min] 3. Geriatric considerations: decreasing oral absorption; decreasing plasma protein concentration; decreasing muscle mass; increasing body fat; decreasing liver/renal function; multiple drugs; multiple diseases. [10 min] 4. Selectivity of drug: drugs are only selective - rather than specific - in their actions; selectivity can be measured by comparing binding affinities of a drug to different receptors or by comparing ED50s for different effects of a drug in vivo; in drug development and in clinical medicine, selectivity is usually considered by separating effects into two categories: beneficial or therapeutic effects versus toxic effects. [10 min] | |||
三、教学重点与难点 | |||
1.教学重点 Variations in drug responsiveness: alteration in concentration of drug that reaches the receptor; variations in concentration of an endogenous receptor ligand; alterations in number or function of receptors; changes in components of response distal to the receptor. 2.教学难点 Receptor regulation: synthesis and degradation, covalent modification, association with other regulatory proteins, relocalization within the cell; be subject to feedback by their own signaling outputs. | |||
四、教学方法选择 | |||
1. 理论课堂教学 A. 多媒体教学:(简要列出本章节多媒体教学设计特点及优势) By using multimedia including PPT, cartoon, video in the teaching learning process, we convey vast information and provide many sources from which student can access the information. The Multimedia approach may improve the teaching learning process, provide the opportunity for the students to gain mastery of competencies and skills, and enable the students to get access to information in dynamic environment. B. 互动教学:(根据实际情况列出案例/实例讨论、分析讨论、分组讨论、翻转课堂等互动教学内容标题) Why is biotransformation necessary for some drugs? Where does drug biotransformation occur? 2. 实验教学:(简要列出实验内容标题) | |||
五、更新或补充内容提要 | |||
六、复习思考题 | |||
What is the major role of biotransformation? What are the enzymes involved in biotransformation? | |||
七、学习资源、课外自主学习参考 | |||
(可以列出供学生进一步学习、拓展本章节内容的网站、著作、期刊的名称及内容等) 朱依谆主编. 药理学第八版, 北京, 人民卫生出版社, 2019 Oxford Textbook of Clinical Pharmacology and Drug Therapy David Grahame-Smith , Jeffrey Aronson. Edition: 3 Clinical Pharmacology Made Incredibly Easy! (Incredibly Easy! Series) Springhouse , 2008 Edition: 3Rev Ed. |
苏州大学医学部药学院授课教案
授课教师:镇学初授课日期:2020.09.18
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic & Clinical Pharmacology, 14th edition | 授课年级 | 2018药学 |
授课章节 | Chapter 6 Introduction to autonomic pharmacology | 授课时间 | 100分钟 |
| |||
| |||
| |||
| |||
| |||
(1)The pharmacological actions of the cholinergic and adrenergic receptors | |||
| |||
A. 多媒体教学: B. 互动教学:
| |||
| |||
| |||
| |||
The ANS in the physiopathology of the eye. |
苏州大学医学部药学院授课教案
授课教师:镇学初授课日期:2020.09.22
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic & Clinical Pharmacology, 14th edition | 授课年级 | 2018药学 |
授课章节 | Chapter 7 Cholinoceptor activating & cholinesterase- inhibiting drugs | 授课时间 | 100分钟 |
| |||
1. 知识目标: (1) To learn the Classification of cholinoceptor-activating drugs, chemical structures and mechanism of action. (2) To learn the pharmacological effects of cholinoceptor-activating drugs. (3) To learn the classification and physiologic function of efferent nerve. (4) To understand major adverse reactions of cholinoceptor-activating drugs. (5) To understand the pharmacological effects and therapeutic applications of cholinersterase-inhibiting drugs. 2. 技能(能力)目标: (1) To describe the pharmacological effects of cholinoceptor-activating drugs. (2) To describe the pharmacological effects of cholinersterase-inhibiting drugs. | |||
| |||
| |||
| |||
(1) The classification of cholinoceptor-activating drugs, chemical structures and mechanism of action (2) The pharmacological effects of cholinoceptor-activating drugs (3) The classification and physiologic function of efferent nerve (4) The major adverse reactions of cholinoceptor-activating drugs (5) The pharmacological effects and therapeutic applications of cholinersterase-inhibiting drugs.
(1)The pharmacological effects and therapeutic applications of cholinersterase-inhibiting drugs. | |||
| |||
A. 多媒体教学: B. 互动教学:
| |||
| |||
| |||
1. To describe Pharmacological effects of cholinoceptor-activating drugs. 2. To describe Pharmacological effects of cholinersterase-inhibiting drugs. 3. To describe the therapeutic applications of cholinersterase-inhibiting drugs. | |||
|
苏州大学医学部药学院授课教案
授课教师:镇学初授课日期:2020.09.23
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic & Clinical Pharmacology, 14th edition | 授课年级 | 2018药学 |
授课章节 | Chapter 8 Cholinoceptor-blocking drugs | 授课时间 | 100分钟 |
| |||
1. 知识目标: (1) To learn the pharmacological actions and therapeutic uses of cholinoceptor-bloking drugs.(2) To learn the major adverse reactions of cholinoceptor-bloking drugs.(3) To understand major adverse reactions of cholinoceptor-activating drugs.(4) To understand the classification and structure of cholinoceptor- bloking drugs.(5) To understand the mechanisms of action of cholinoceptor-bloking drugs. 2.技能(能力)目标: (1) To describe the pharmacological actions and therapeutic uses of cholinoceptor-bloking drugs. | |||
| |||
| |||
| |||
(1) The pharmacological actions and therapeutic uses of cholinoceptor-bloking drugs (2) The major adverse reactions of cholinoceptor-bloking drugs
(1) The pharmacological actions of the cholinergic and adrenergic receptors | |||
| |||
A. 多媒体教学: B. 互动教学:
| |||
| |||
| |||
(1) To describe the muscarinic receptor subgroups and their antagonists. (2) To describe the pharmacological effects of atropine. (3) To describe the clinical uses of muscarinic blocking drugs. | |||
|
苏州大学医学部药学院授课教案
授课教师:镇学初授课日期:2020.09.25
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic & Clinical Pharmacology, 14th edition | 授课年级 | 2018药学 |
授课章节 | Chapter 9 Adrenoceptor Activating Drugs | 授课时间 | 100分钟 |
| |||
1. 知识目标: (1) Distribution of the adrenoceptor subtypes. (2) Effects of stimulation of different adrenergic receptors. (3) To learn the effect of sympathomimetic drugs on cardiavascular system. (4) To learn the cardiovascular clinical use of sympathomimetic drugs. (5) To understand the effect of sympathomimetic drugs on eye, respiratory tract, gastrointestinal tract, genitourinary tract, and exocrine glands system. (6) To learn the actions and clinical uses of NA, AD, ISOP and DA. (7) To understand the effects and clinical uses of ephedrine, mephentermin, metaraminol and phenylephrine. 2.技能(能力)目标: (1) To describe the pharmacological mechanism of cardiovascular application of sympathomimetic drugs. | |||
| |||
1. Identification of adrenoceptors. [5 min] 2. Molecular mechanism of sympathomimetic action. [10 min] 3. Receptor regulation. [10 min] 4. Effects of stimulation of α- and β–adrenergic receptors [10 min] 5. The effect of sympathomimetic drugs on cardiovascular system. [5 min] 6. The effect on other organs. [5 min] 7. Cardiovascular applications. [15 min] 8. Pulmonary applications. [5 min] 9. Other applications. [5 min] 10. Classification of adrenergic drugs [5 min] 11. Discussion ofαand β-R agonists: adrenaline dopamine ephedrine [5 min] 12. Discussion of α-R agonists: noradrenaline mephentermin, metaraminol and phenylephrine [5 min] 13. Discussion of β–R agonists :isoproterenol [5 min] | |||
| |||
(1) The effect of sympathomimetic drugs on cardiavascular system. (2) The cardiovascular clinical use of sympathomimetic drugs. (3) The effect of sympathomimetic drugs on eye, respiratory tract, gastrointestinal tract, genitourinary tract, and exocrine glands system. (4) The actions and clinical uses of NA, AD, ISOP and DA.
(1) The pharmacological mechanisms of cardiovascular application of sympathomimetic drugs. | |||
| |||
A. 多媒体教学: B. 互动教学:
| |||
| |||
| |||
| |||
|
苏州大学医学部药学院授课教案
授课教师:镇学初授课日期:2020.09.27
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic & Clinical Pharmacology, 14th edition | 授课年级 | 2018药学 |
授课章节 | Chapter 10 Adrenoceptor Antagonist Drugs | 授课时间 | 100分钟 |
| |||
1. 知识目标: (1) To learn the actions and clinical use of phentolamine. (2) To understand the adverse effects of α-adrenergic blockers. (3) To understand the pharmacological action of α1 receptor blockers. (4) To learn the pharmacological action and clinical use of β-R blockers ISA. (5) To understand the adverse effects of β-adrenergic blockers. 2.技能(能力)目标: (1) To describe the pharmacological mechanism of cardiovascular application of sympathomimetic drugs. | |||
| |||
1. Classification of anti-adrenergic drugs. [10 min] 2. Pharmacological effects after blocking adrenergic receptors. [10 min] 3. Effects not related to the blocking of β receptor. [10 min] 4. Pharmacological effects and therapeutic applications of α-R blockers including phentolamine, tolazoline, phenoxybenzamine, and prazosin. [15 min] 5. Classification of β-adrenergic blockers. [10min] 6. Pharmacological effects of β-adrenergic blockers. [15 min] 7. Therapeutic applications of β-adrenergic blockers. [10 min] 8. Adverse effects of β-adrenergic blockers. [10 min] 9. Features of selective β1 receptor blockers and β-adrenergic blockers with ISA. [10 min] | |||
| |||
(1) The action and clinical use of phentolamine. (2) The adverse effects of α-adrenergic blockers. (3) The pharmacological action and clinical use of β-R blockers ISA. (4) The pharmacological action of α1 receptor blockers..
(1) The pharmacological action and clinical use of β-R blockers ISA. | |||
| |||
A. 多媒体教学: B. 互动教学:
| |||
| |||
| |||
1. Why can phentolamine not be used in constitutional hypertension? 2. Can β-adrenergic blockers be used for heart failure clinically? 3. What are effects of rennin angiotensin system on the blood pressure? | |||
|
苏州大学医学部药学院授课教案
授课教师:贾佳、张丽授课日期:2020.09.29
PBL (Autonomic Drugs)
2 hours
苏州大学医学部药学院授课教案
授课教师:王光辉授课日期:2020.09.30
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic & Clinical Pharmacology, 14th edition | 授课年级 | 2018药学 |
授课章节 | Chapter 21 Introduction to the Pharmacology of CNS Drugs | 授课时间 | 50分钟 |
| |||
1. 知识目标: (1) To learn the actions and clinical use of phentolamine. (2) To understand the adverse effects of α-adrenergic blockers. (3) To understand the pharmacological action of α1 receptor blockers. (4) To learn the pharmacological action and clinical use of β-R blockers ISA. (5) To understand the adverse effects of β-adrenergic blockers. 2.技能(能力)目标: (1) To describe the pharmacological mechanism of cardiovascular application of sympathomimetic drugs. | |||
| |||
1. Classification of anti-adrenergic drugs. [10 min] 2. Pharmacological effects after blocking adrenergic receptors. [10 min] 3. Effects not related to the blocking of β receptor. [10 min] 4. Pharmacological effects and therapeutic applications of α-R blockers including phentolamine, tolazoline, phenoxybenzamine, and prazosin. [15 min] 5. Classification of β-adrenergic blockers. [10min] 6. Pharmacological effects of β-adrenergic blockers. [15 min] 7. Therapeutic applications of β-adrenergic blockers. [10 min] 8. Adverse effects of β-adrenergic blockers. [10 min] 9. Features of selective β1 receptor blockers and β-adrenergic blockers with ISA. [10 min] | |||
| |||
(1) The action and clinical use of phentolamine. (2) The adverse effects of α-adrenergic blockers. (3) The pharmacological action and clinical use of β-R blockers ISA. (4) The pharmacological action of α1 receptor blockers..
(1) The pharmacological action and clinical use of β-R blockers ISA. | |||
| |||
A. 多媒体教学: B. 互动教学:
| |||
| |||
| |||
1. Why can phentolamine not be used in constitutional hypertension? 2. Can β-adrenergic blockers be used for heart failure clinically? 3. What are effects of rennin angiotensin system on the blood pressure? | |||
|
苏州大学医学部药学院授课教案
授课教师:王光辉授课日期:2020.09.30
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic & Clinical Pharmacology, 14th edition | 授课年级 | 2018药学 |
授课章节 | Chapter 22Sedative and hypnotics | 授课时间 | 50分钟 |
| |||
1. 知识目标: (1) Master Chemical Classification of Sedative-Hypnotics (2) Master Pharmacodynamics of Sedative-Hypnotics (3) Master Tolerance; Psychologic & Physiologic Dependence of Sedative-Hypnotics (4) Master Antagonists of Sedative-Hypnotics (5) Master Clinical Toxicology of Sedative-Hypnotics (6) Master Pharmacokinetics of Sedative-Hypnotics 2.技能(能力)目标: | |||
| |||
(5 min)
| |||
| |||
1. 教学重点 (1) Chemical Classification of Sedative-Hypnotics(2) Pharmacodynamicsof Sedative-Hypnotics(3) Antagonists of Sedative-Hypnotics2. 教学难点 (1) Tolerance; Psychologic & Physiologic Dependence(2) Clinical Toxicology of Sedative-Hypnotics | |||
| |||
A. 多媒体教学: B. 互动教学: 实验教学: | |||
| |||
Introduce structure of sleep Dosages of drugs used commonly for sedation and hyponosis | |||
| |||
What are the advantages and Disadvantages of benzodiazepines for treatment of anxiety states | |||
Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy. David E. Golan, 4th Edition, 2016 |
苏州大学医学部药学院授课教案
授课教师:王光辉授课日期:2020.10.09
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic & Clinical Pharmacology, 14th edition | 授课年级 | 2018药学 |
授课章节 | Chapter 24Antiseizure drugs | 授课时间 | 100分钟 |
| |||
1. 知识目标: (1) Master Seizure types(2) Master Drugs Used in Partial Seizures & Generalized Tonic-Clonic Seizures(3) Master Drugs Used in Generalized Seizures(4) Master Antiseizures classification(5)Understand Drug mechanisms(6) Understand Drug chemistry2.技能(能力)目标: | |||
| |||
Mechanism of Action; clinical use; Pharmacokinetics; Drug Interactions; Toxicity
(1) Ethosuximide; (2) Valproic Acid & Sodium Valproate; (3) Benzodiazepines Mechanism of Action; clinical use; Pharmacokinetics; Drug Interactions; Toxicity
Carbamazepine. Phenytoin, valproic acid
Ethosuximide, valproic acid, clonazepam
Valproic acid, clonazepam, nitrazepam, or other benzodiazepines | |||
| |||
(1) Drugs Used in Partial Seizures & Generalized Tonic-Clonic Seizures (2) Drugs Used in Generalized Seizures (3) Antiseizures classification
(1) Seizure types | |||
| |||
A. 多媒体教学: B. 互动教学:
| |||
| |||
Drug development for Epilepsy | |||
| |||
| |||
Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy. David E. Golan, 4th Edition, 2016 |
苏州大学医学部药学院授课教案
授课教师:王光辉授课日期:2020.10.13
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic & Clinical Pharmacology, 14th edition | 授课年级 | 2018药学 |
授课章节 | Chapter 31 Opoid analgesics and antagonists | 授课时间 | 100分钟 |
| |||
1. 知识目标: (1) To learn the major pharmacological effects, clinical applications, and the major side effects of morphine. (2) To understand the mechanisms of opioid. (3) To understand the major pharmacological effects and clinical applications of codeine, pethidine, and pentazoin. 2.技能(能力)目标: | |||
| |||
1. Classes of analgesic drugs. [5 min] 2. Discovery of opioid and morphine. [5 min] 3. Morphine receptor: distribution and the action mechanism of morphine. [7 min] 4. Pharmacological effects of morphine. [20 min] 5. Analgesia and sedation, Respiratory depression, Emesis and nausea, Cough reflex, Miosis. [8 min] 6. Cardiovascular system, Smooth muscle. [5 min] 7. Tolerance and physical dependence, addiction. [5 min] 8. Clinical applications and side effects of morphine. [5min] 9. Pharmacokinetics of morphine. [5min] 10. Major pharmacological effects and clinical applications of codeine, pethidine, Methadone Fentanyl pentazoin. [20 min] 11. Opioid Antagonists—Naloxone: clinic use and research use. [5 min] 12. Drug abuse. [10 min] | |||
| |||
The major pharmacological effects, clinical applications, and the major side effects of morphine.
The mechanisms of opioid | |||
| |||
A. 多媒体教学: B. 互动教学:
| |||
| |||
Discovery and harm of opium | |||
| |||
1. What are the pharmacological effects and clinic uses of morphine? Which main side effect of morphine limits its wide uses? 2. Compared with morphine, can you tell the clinic uses of pethidine? 3. Please compare the analgesic effects of aspirin and morphine. 4. How many classes of analgesics are currently in clinic use? How are these drugs selected? | |||
Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy. David E. Golan, 4th Edition, 2016 |
苏州大学医学部药学院授课教案
授课教师:王光辉授课日期:2020.10.16
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic & Clinical Pharmacology, 14th edition | 授课年级 | 2018药学 |
授课章节 | Chapter 36 Nonsterodal anti-inflammatory drug | 授课时间 | 100分钟 |
| |||
1. 知识目标: (1) To learn the pharmacological effects, clinical applications and adverse effects of aspirin and acetaminophen. (2) To understand the pharmacological action and clinical application of ibuprofen. (3) To understand the identical characters of anti-inflammatory drugs. (4) To understand the differences between the non-selective and selective COX-2 inhibitor. 2.技能(能力)目标: | |||
| |||
1. NSAIDs and their common characters. 20 min 1) Antipyretic Effect: (1). Decrease high fever body temperature to normal level, has no effect on normal body temperature. (2). Mechanism: Inhibit pyrogen–induced production of prostaglandins in the hypothalamus. 2). Anti-Analgesic Effect (1). N-anesthesia Anti-analgesic drugs don’t cause euphoria, tolerance, respiratory depression. (2). The intensity of Anti-analgesic effect are lower than pethidine. (3). Effect on chronic dull pain and no effect on sharp pain. (4). Mechanism : Inhibit the synthesis of prostaglandins and alleviate analgesic action. The action site is mainly in peripheral. 3). Anti-inflammatory Effect (1). All NSAIDs but acetaminophen can alleviate inflammation. (2). Locally inhibit the synthesis of PG 2. Aspirin. 30 min About Aspirin Mechanism of aspirin COX-1,COX-2 Antipyretic-Analgesic and Anti-inflammatory effects Inhibition of Platelet Aggregation and thrombosis. Side effects 3. Acetaminophen. 10 min Comparison with aspirin. 4. The pharmacological effects and clinical applications of ibuprofen. 10 min 5. The identical characters of anti-inflammatory drugs. Selective COX-2. 10 min 6. Other anti-inflammatory drugs, including to clofenami acid, nimesulide, piroxicam, naproxen. 20 min | |||
| |||
To learn the pharmacological effects, clinical applications and adverse effects of aspirin and acetaminophen.
(4) To understand the differences between the non-selective and selective COX-2 inhibitor. | |||
| |||
A. 多媒体教学: B. 互动教学:
| |||
| |||
The history and new use of aspirin in clinic. | |||
| |||
1). What are the pharmacological effects, clinic uses and the main side effects of aspirin and ibuprofen? 2). What are the the difference in modifying body temperature between aspirin and chlorpromazine. | |||
Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy. David E. Golan, 4th Edition, 2016 |
苏州大学医学部药学院授课教案
授课教师:盛瑞授课日期:2020.10.20
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic & Clinical Pharmacology, 14th edition | 授课年级 | 2018级药学英文班 |
授课章节 | Chapter 15 Diuretic Agents | 授课时间 | 100分钟 |
| |||
(1) To learn the classification of diuretics.(2) To learn the mechanism of diuretics.(3) To learn the pharmacological effects and clinical applications of diuretics.(4) To understand the major adverse reactions of diuretics.(5) To understand the renal urinary physiology and site of action of diuretics. 2. 技能(能力)目标: | |||
| |||
1. Introduction (30 min) (1) Discovery The early diuretic measures The discovery of thiazide diuretics and other diuretics (2) Renal urinary physiology and site of action of diuretics Renal Glomerulus, Renal Tubules, Proximal Convoluted Tubule, Ascending Loop of Henle, Distal Convoluted Tubule and Collecting Duct 2. Classification of diuretics (5 min) (1) Loop or high-ceiling diuretics (2) Thiazides and related agents (3) Potassium-sparing diuretics (4) Carbonic anhydrase inhibitors 3. Loop or high-ceiling Diuretics (15 min) (1) Pharmacological effects Diuretic effects, Effects on renal hemodynamics (2) Pharmacokinetics, Adverse Effects, Drug interactions 4. Thiazides and related agents (15 min) (1) Pharmacological Effects Mechanism of action Effect against diabetes insipidus, Depressor effects (2) Pharmacokinetics, Adverse Effects 5. Potassium-sparing diuretics (5 min) (1) Spironolactone (antisterone) (2) Triamterene and amiloride 6. Carbonic anhydrase inhibitors (2 min) 7. Osmotic diuretics (3 min) Therapeutic applications 8. Summary (5 min) | |||
三、教学重点与难点 | |||
1.教学重点 Classification of diuretics (5 min) (1) Loop or high-ceiling diuretics (2) Thiazides and related agents (3) Potassium-sparing diuretics (4) Carbonic anhydrase inhibitors 2.教学难点 Renal urinary physiology and site of action of diuretics Renal Glomerulus, Renal Tubules, Proximal Convoluted Tubule, Ascending Loop of Henle, Distal Convoluted Tubule and Collecting Duct | |||
四、教学方法选择 | |||
1. 理论课堂教学 A. 多媒体教学:(简要列出本章节多媒体教学设计特点及优势) By using multimedia including PPT, cartoon, video in the teaching learning process, we convey vast information and provide many sources from which student can access the information. The Multimedia approach may improve the teaching learning process, provide the opportunity for the students to gain mastery of competencies and skills, and enable the students to get access to information in dynamic environment. B. 互动教学:(根据实际情况列出案例/实例讨论、分析讨论、分组讨论、翻转课堂等互动教学内容标题) Which kind of diuretics can cause potassium depletion? The history and development of treatment strategies of diuretics. 2. 实验教学:(简要列出实验内容标题) | |||
五、更新或补充内容提要 | |||
六、复习思考题 | |||
1. How are the diuretics classified? Please give an example for each group. 2. Which diuretics can conserve potassium and how can this property be utilized? 3. What are the similarities and differences between the loop diuretics and thiazides? | |||
七、学习资源、课外自主学习参考 | |||
(可以列出供学生进一步学习、拓展本章节内容的网站、著作、期刊的名称及内容等) 朱依谆主编. 药理学第八版, 北京, 人民卫生出版社, 2019 Oxford Textbook of Clinical Pharmacology and Drug Therapy David Grahame-Smith , Jeffrey Aronson. Edition: 3 Clinical Pharmacology Made Incredibly Easy! (Incredibly Easy! Series) Springhouse , 2008 Edition: 3Rev Ed. |
苏州大学医学部药学院授课教案
授课教师:盛瑞授课日期:2020.10.23
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic & Clinical Pharmacology, 14th edition | 授课年级 | 2018级药学英文班 |
授课章节 | Chapter 11 Agents Used in Cardiac Arrhythmias | 授课时间 | 100分钟 |
| |||
2. 技能(能力)目标: | |||
| |||
1. The electrophysiology background of arrhythmias (Proarrhythmias). (20 min) Membrane Potential of Cardiac Cell. Fast and slow responses. Membrane responsibility and conductivity speed. Effective refractory period. 2. The electrophysiology mechanism of Arrhythmias. (20 min) (1).Abnormal impulse generation (automatic or triggered). Delayed after-depolarisation and Early after-depolarizations. (2).Abnormal impulse conduction. Re-entry, Abnormal pacemaker activity and Heart block. 3. The basic electrophysiology effect of antiarrhythmic Drugs. (10 min) 4. The classification of anti-arrhythmic drugs (Singh-Vaughan Williams Classification). (10 min) Sodium Channel Blockers. βreceptor Blockers. Potassium Channel Blockers. Calcium Channel Blockers. 5. The mechanisms by which different antiarrhythmic drugs are thought to act. (15 min) 6. The anti-arrhythmic drugs used commonly for clinical application. (10 min) 7. The therapeutic principle of swift arrhythmia and the reasonable application of drugs. (10 min) 8. Summary. (5 min) | |||
| |||
The classification of anti-arrhythmic drugs (Singh-Vaughan Williams Classification).
The electrophysiology mechanism of Arrhythmias. | |||
| |||
A. 多媒体教学:(简要列出本章节多媒体教学设计特点及优势) By using multimedia including PPT, cartoon, video in the teaching learning process, we convey vast information and provide many sources from which student can access the information. The Multimedia approach may improve the teaching learning process, provide the opportunity for the students to gain mastery of competencies and skills, and enable the students to get access to information in dynamic environment. B. 互动教学:(根据实际情况列出案例/实例讨论、分析讨论、分组讨论、翻转课堂等互动教学内容标题) (1)分析讨论 Which drug is used together with quinidine in the treatment of atrial flutter? Why? (2)实例讨论 Although major development in the past decade has achieved in the therapy of arrhythmias, currently available drugs is hazardous, unpredictable, and often ineffective. The therapeutic index of antiarrhythmic drugs is very narrow. Physicians prescribing these agents must be thoroughly familiar with the indications, contraindications, toxicities and pharmacological properties of the drug used. The selection of a particular drug therapy should be based on the "clinical value" by an assessment of benefits and risks of treatment.
| |||
| |||
| |||
1. How many types of antiarrhythmic drugs and what are the prototypic agents in each group? 2. Definition: Cinchonism | |||
| |||
(可以列出供学生进一步学习、拓展本章节内容的网站、著作、期刊的名称及内容等) 朱依谆主编. 药理学第八版, 北京, 人民卫生出版社, 2019 Oxford Textbook of Clinical Pharmacology and Drug Therapy David Grahame-Smith , Jeffrey Aronson. Edition: 3 Clinical Pharmacology Made Incredibly Easy! (Incredibly Easy! Series) Springhouse , 2008 Edition: 3Rev Ed. |
苏州大学医学部药学院授课教案
授课教师:盛瑞授课日期:2020.10.27
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic & Clinical Pharmacology, 14th edition | 授课年级 | 2018级药学英文班 |
授课章节 | Chapter 14 Antihypertensive Drugs | 授课时间 | 100分钟 |
| |||
(1) To learn the major types of antihypertensive drugs and their mechanisms. (2) To understand the name of the prototype drugs of each major type. 2. 技能(能力)目标: | |||
| |||
1. Review of the physiology of blood pressure regulation. [20 min] 2. Pathophysiology of hypertension. [20 min] 3. Individual introduction of the major types of antihypertensive drugs. [50 min] (1)Sympathoplegic agents Centrally acting sympatholegic drugs: clonidine, methyldopa Ganglion blocking agents: trimethaphan Adrenergic neuron-blocking agents: guanethidine, reserpine Adrenergic blockers: propranolol, prazosin (2)Agents that block production or action of angiotensin Angiotensin Converting Enzyme Inhibitors: captopril Angiotensin Receptor blockers: losartan (3)Diuretics: hydrochlorothiazide (4)Direct vasodilators Calcium Channel Blockers: nifedipine Peripheral Vasodilators: hydralazine, nitroprusside, minoxidil 4. Summary. [10 min] | |||
| |||
The first line therapy of antihypertensive drugs
The regulation of hypertension by RAAS system | |||
| |||
A. 多媒体教学:(简要列出本章节多媒体教学设计特点及优势) By using multimedia including PPT, cartoon, video in the teaching learning process, we convey vast information and provide many sources from which student can access the information. The Multimedia approach may improve the teaching learning process, provide the opportunity for the students to gain mastery of competencies and skills, and enable the students to get access to information in dynamic environment. B. 互动教学:(根据实际情况列出案例/实例讨论、分析讨论、分组讨论、翻转课堂等互动教学内容标题) Case-study: Antihypertensive Drugs The physiological bases of blood pressure regulation. Major organs related to blood pressure regulation.
| |||
| |||
| |||
1. The pharmacological bases of diuretics in treating hypertension. 2. Difference and similarities between ACEI and Ang II receptor antagonists in their actions and side effects. | |||
| |||
(可以列出供学生进一步学习、拓展本章节内容的网站、著作、期刊的名称及内容等) 朱依谆主编. 药理学第八版, 北京, 人民卫生出版社, 2019 Oxford Textbook of Clinical Pharmacology and Drug Therapy David Grahame-Smith , Jeffrey Aronson. Edition: 3 Clinical Pharmacology Made Incredibly Easy! (Incredibly Easy! Series) Springhouse , 2008 Edition: 3Rev Ed. |
苏州大学医学部药学院授课教案
授课教师: 张慧灵授课日期:2020.10.30
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic & Clinical Pharmacology, 14th edition | 授课年级 | 2018药学 |
授课章节 | Chapter 12 Vasodilators and the treatment of angina pectoris | 授课时间 | 100 min |
| |||
(1)To learn the pharmacological effects, therapeutic applications and major adverse reactions of antianginal agents. (2) To learn the mechanisms of relief of symptoms of angina pectoris by antianginal agents. (3) To know the classification of antianginal agents. 2. 技能(能力)目标: (1) To train the abilities how to learn systematically and to achieve mastery through a comprehensive study of the subject; (2) To train the ability how to co-operation with others in group study; (3) To train the ability to deliver a presentation; (4) To train the creative thinking by learning the drug history of discovery of Nitrates and Nitrites. | |||
| |||
I. Introduction 10 min [Angina pectoris] [The types of angina pectoris] II. Pathophysiology of angina pectoris 7 min III. Basic pharmacological action of drugs used to treat angina pectoris 3 min IV. Drugs used to treat angina pectoris ●Nitrates and Nitrites40 min [History] [Pharmacological action] [Mechanism of relief of symptoms of angina pectoris] [Molecular Mechanism of relaxing smooth muscle ] [Pharmacokinetics] [Clinical use] [Toxicity & Tolerance] ●Beta-adrenoceptor blocking drugs (β blockers) 20 min [Mechanism of relief of symptoms of angina pectoris] [Therapeutic applications] [Beneficial effect of the combination of β-blockers and nitrates] [Adverse effects] ●Calcium channel blocking drugs(Calcium channel blockers ) 30 min [ Classification of calcium channel blockers] [Pharmacokinetics] [Pharmacological action] [Clinical use] [Mechanisms of relief of symptoms of angina pectoris] [Adverse effects] | |||
| |||
(1)The pharmacological effects, therapeutic applications and major adverse reactions of antianginal agents. (2) Actionmechanism of Nitrates and Nitrites, β blockers and calcium channel blockers in the treatment of angina pectoris. (3) Beneficial effect of the combination of β-blockers and nitrates or the combination of β-blockers and calcium channel blockers. (4) The differences of Nitrates and Nitrites, β blockers and calcium channel blockers in the application of angina pectoris.
(1) Action mechanism of Nitrates and Nitrites, β blockers and calcium channel blockers in the treatment of angina pectoris. (2) Beneficial effect of the combination of β-blockers and nitrates or the combination of β-blockers and calcium channel blockers. | |||
| |||
A. 多媒体教学: Animation; Images; Graphs and tables; Video B. 互动教学:
| |||
| |||
The application of asprin in the treatment of angina pectoris. | |||
| |||
1. Why are Nitrates and Nitrites, β blockers and calcium channel blockers used to treat angina pectoris. 2. What are the beneficial effect of the combination of β-blockers and nitrates or the combination of β-blockers and calcium channel blockers? 3. Please describe the differences of Nitrates and Nitrites, β blockers and calcium channel blockers in the application of angina pectoris. 4. Can β blockers be used to treat unstable angina? Why? | |||
| |||
Learn more at http://www.heart.org |
苏州大学医学部药学院授课教案
授课教师:张慧灵授课日期:2020. 11.6; 2020.11.10
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic & Clinical Pharmacology, 14th edition | 授课年级 | 2018药学 |
授课章节 | Chapter 13 Drugs used in heart failure | 授课时间 | 200 min |
| |||
(1).To learn the pharmacological effects, therapeutic applications and major adverse reactions of cardiac glycosides. (2). To learn the action mechanisms of cardiac glycosides, renin—angiotensin—aldosterone system inhibitors , β-adrenoceptor blockers, Diuretics in the treatment of heart failure. (3). To know the action mechanisms of the other drugs used in heart failure. (4). To know the classification of drugs used in heart failure. 2. 技能(能力)目标: (1) To train the abilities how to learn systematically and to achieve mastery through a comprehensive study of the subject; (2) To train the ability how to co-operation with others in group study; (3) To train the ability to deliver a presentation; (4) To train the creative thinking by learning the drug history of cardiac glycosides and the development of drugs used in heart failure. | |||
| |||
I. Introduction 5 min [Heart failure] II. Pathophysiology of angina pectoris 20 min III. Classification of drugs used in heart failure 5 min IV. Drugs used to treat heart failure ●Cardiac glycosides 70 min [History] [Pharmacological action and Mechanisms of action] [Pharmacokinetics] [Clinical use] [Adverse effects and toxicity treatment] ●renin—angiotensin—aldosterone system inhibitors30 min [Therapeutic effects of Angiotensin Converting enzyme (ACE) inhibitors in heart failure] [Therapeutic effects of Angiotensin receptor blockers in heart failure] ●Beta-adrenoceptor blocking drugs (β blockers)20 min [Therapeutic effects of β blockers in heart failure]30 min ●Other agents used in CHF20 min (1) Diuretics: Hydrochlorothiazide, Spironolactone (2) Vasodilators: hydralazine, isosorbide dinitrate (3) β1-selective adrenoceptor agonists (4) Phosphodiesterase(PDE)inhibitors (5) Calcium channel blockers | |||
| |||
(1). The pharmacological effects, therapeutic applications and major adverse reactions of cardiac glycosides. (2). The action mechanisms of cardiac glycosides, renin—angiotensin—aldosterone system inhibitors , β-adrenoceptor blockers, Diuretics in the treatment of heart failure. (3). The action mechanisms of the other drugs used in heart failure.
(1) The mechanisms of positive inotropic effect of cardiac glycosides. (2)Electrical effects of cardiac glycosides. (3) The action mechanisms of cardiac glycosides, renin—angiotensin—aldosterone system inhibitors and β-adrenoceptor blockers in the treatment of heart failure. | |||
| |||
A. 多媒体教学: Animation; Images; Graphs and tables; Video B. 互动教学:
Effects of drugs on ventricular stroke output of isolated heart of frog in situ | |||
| |||
The application of renin—angiotensin—aldosterone system inhibitors and β-adrenoceptor blockers in the treatmentof heart failure induced by myocardial infarction. | |||
| |||
1. What are the therapeutic mechanisms of cardiac glycosides, renin—angiotensin—aldosterone system inhibitors or β-adrenoceptor blockers in the treatment of heart failure. 2. Why do cardiac glycosides bring about inotropic effect? 3. What are the therapeutic mechanisms of cardiac glycosides in supraventricular arrhythmias ? 4. What are the drug therapy for digoxin-induced arrhythmias ? | |||
| |||
Learn more at http://www.heart.org |
苏州大学医学部药学院授课教案
授课教师:张慧灵授课日期:2020.11.13
GBL (Cardiovascular-renal Drugs)
\
\
苏州大学医学部药学院授课教案
授课教师:贾佳授课日期:2020.11.17
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic & Clinical Pharmacology, 14th edition | 授课年级 | 2018级药学英文班 |
授课章节 | Chapter 33 Agents used in anemia | 授课时间 | 100分钟 |
| |||
To understand the clinical application and major adverse reactions of iron, folic acid, and vitamin B12. 2. 技能(能力)目标: | |||
| |||
1. Diminished Production/Replacement of RBC’s Anemia[20 min] Microcytic anemia – deficiency of Fe Megaloblastic anemia/Macrocytic anemia- deficiency of folic acid and B12 Normocytic anemia – deficiency of Erythropoietin 2. Iron. [20 min] Factors influencing iron absorption Mechanism of Iron Absorption Therapeutic uses of Iron Iron Preparations Toxicity of Iron Overdose 3. Folic Acid[20 min] Enzymatic reactions that use folates Therapeutic Uses of Folic Acid 4.Vitamin B12(Cyanocobalamin)-Pernicious anemia[20 min] Enzymatic reactions that use vitamin B12 Mechanism for VitB12 Therapeutic Uses of B12 4. Normocytic anemia -Hematopoietic growth factors[10 min] Sites of action for EPO Therapeutic Uses 5.Summary[10 min] | |||
三、教学重点与难点 | |||
1.教学重点 Microcytic anemia –Fe Megaloblastic anemia/Macrocytic anemia- folic acid and B12 Normocytic anemia –Erythropoietin 2.教学难点 Enzymatic reactions that use folates and vitamin B12 | |||
四、教学方法选择 | |||
1. 理论课堂教学 A. 多媒体教学:(简要列出本章节多媒体教学设计特点及优势) By using multimedia including PPT, cartoon, video in the teaching learning process, we convey vast information and provide many sources from which student can access the information. The Multimedia approach may improve the teaching learning process, provide the opportunity for the students to gain mastery of competencies and skills, and enable the students to get access to information in dynamic environment. B. 互动教学:(根据实际情况列出案例/实例讨论、分析讨论、分组讨论、翻转课堂等互动教学内容标题) Case study-Agents used in anemia What type of anemia should they be used, respectively? 2. 实验教学:(简要列出实验内容标题) | |||
五、更新或补充内容提要 | |||
六、复习思考题 | |||
What are the representative drugs used in anemia? What type of anemia should they be used, respectively? | |||
七、学习资源、课外自主学习参考 | |||
(可以列出供学生进一步学习、拓展本章节内容的网站、著作、期刊的名称及内容等) 朱依谆主编. 药理学第八版, 北京, 人民卫生出版社, 2019 Oxford Textbook of Clinical Pharmacology and Drug Therapy David Grahame-Smith , Jeffrey Aronson. Edition: 3 Clinical Pharmacology Made Incredibly Easy! (Incredibly Easy! Series) Springhouse , 2008 Edition: 3Rev Ed. |
苏州大学医学部药学院授课教案
授课教师: 贾佳 授课日期:2020.11.20
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic & Clinical Pharmacology, 14th edition | 授课年级 | 2018级药学英文班 |
授课章节 | Chapter 34 Drugs Used in Disorders of Coagulation | 授课时间 | 100分钟 |
| |||
(1). To learn the pharmacological action, clinical application, and adverse reaction of heparin, coumarin derivatives, streptokinase, urokinase, vitamin K, aspirin. (2). To understand the pharmacological action, clinical application of direct thrombin inhibitors clopidogrel, ticlopidine, glycoprotein IIb/IIIa inhibitors and dipyridamole.2. 技能(能力)目标: | |||
| |||
1. Review of the regulation of coagulation and fibrinolysis. [10 min] 2. Anticoagulants Heparin: source and chemistry. pharmacological action and feature, mechanism of action, clinical application, adverse reaction, and intoxication prevention. [20 min] coumarin derivatives (e.g., dicoumarol ,warfarin) : chemistry. pharmacological action and feature, mechanism of action, clinical application, adverse reaction, and intoxication prevention. interaction of drugs. [20 min] 3.fibrinolysis drugs: streptokinase, urokinase. mechanism of action and feature, clinical application, adverse reaction. [10 min] 4.anti-platelet drugs: aspirin, Clopidogrel, Ticlopidine, Glycoprotein IIb/IIIa inhibitors and dipyridamole, mechanism of action, clinical application and assess. [10 min] 5. Drugs used in bleeding disorder (vitamin K): source, mechanism of action, clinical application, and adverse reaction. [10 min] | |||
| |||
To compare heparin with warfarin in treating thromboembolic disorder.
Review of the regulation of coagulation and fibrinolysis. | |||
| |||
A. 多媒体教学:(简要列出本章节多媒体教学设计特点及优势) By using multimedia including PPT, cartoon, video in the teaching learning process, we convey vast information and provide many sources from which student can access the information. The Multimedia approach may improve the teaching learning process, provide the opportunity for the students to gain mastery of competencies and skills, and enable the students to get access to information in dynamic environment. B. 互动教学:(根据实际情况列出案例/实例讨论、分析讨论、分组讨论、翻转课堂等互动教学内容标题) (1). The discovery of heparin. (2). The discovery of aspirin.
| |||
| |||
| |||
1.What are the therapeutic applications of heparin? 2.To compare heparin with warfarin in treating thromboembolic disorder. (include Pharmacokinetics and Mechanism of action) 3. What can be done in treating a hemorrhagic disorder caused by excessive doses of heparin or warfarin? | |||
| |||
(可以列出供学生进一步学习、拓展本章节内容的网站、著作、期刊的名称及内容等) 朱依谆主编. 药理学第八版, 北京, 人民卫生出版社, 2019 Oxford Textbook of Clinical Pharmacology and Drug Therapy David Grahame-Smith , Jeffrey Aronson. Edition: 3 Clinical Pharmacology Made Incredibly Easy! (Incredibly Easy! Series) Springhouse , 2008 Edition: 3Rev Ed. |
苏州大学医学部药学院授课教案
授课教师:张丽授课日期:2020.11.24
课程名称 | Pharmacology IV | 所属学科 | 药理学 |
教材名称 | Basic & Clinical Pharmacology, 14th edition | 授课年级 | 2018 药学 |
授课章节 | Chapter 38 Thyroid & Antithyroid Drugs | 授课时间 | 50分钟 |
| |||
(1) To learn the pharmacological effects, clinical applications and adverse reactions of antithyroid drugs.(2) To understand the effects of thyroid hormones.(3) To understand the mechanisms of action of iodides.
| |||
| |||
1. Biosynthesis of Triiodothyronine (T3) and thyroxine (T4); oxidation and iodination; formation of Thyroxine (T4) and Triiodothyronine (T3); secretion, transportation and degradation of T3 and T4. [10 min] 2. The effects and clinical uses of thyroid hormones. [15 min] 3. Anti-thyroid Drugs [25 min] (1) Thioureas (2) Iodides (3) Radioiodine (4) β-receptor blocking agents | |||
| |||
(1)The effects and clinical uses of thyroid hormones. (2)The effects and clinical uses of Anti-thyroid Drugs
| |||
| |||
By using multimedia including PPT, cartoon, video in the teaching learning process, we convey vast information and provide many sources from which student can access the information. The Multimedia approach may improve the teaching learning process, provide the opportunity for the students to gain mastery of competencies and skills, and enable the students to get access to information in dynamic environment. B. 互动教学: 1)Talk about the effects and clinical uses of thyroid hormones. 2)Talk about the effects and clinical uses of Anti-thyroid Drugs
| |||
| |||
| |||
What the effects and clinical uses of Thioureas? | |||
| |||
朱依谆主编. 药理学第八版, 北京, 人民卫生出版社, 2019 Oxford Textbook of Clinical Pharmacology and Drug Therapy David Grahame-Smith , Jeffrey Aronson. Edition: 3 Clinical Pharmacology Made Incredibly Easy! (Incredibly Easy! Series) Springhouse , 2008 Edition: 3Rev Ed. |
苏州大学医学部药学院授课教案
授课教师:张丽授课日期:2020.11.27
课程名称 | Pharmacology IV | 所属学科 | 药理学 |
教材名称 | Basic & Clinical Pharmacology, 14th edition | 授课年级 | 2018 药学 |
授课章节 | Chapter 39 Adrenocorticosteroids & Adrenocortical Antagonists | 授课时间 | 100分钟 |
| |||
(1) To learn the major pharmacological effects and therapeutic applications of glucocorticoids. (2) To learn the major adverse reactions of glucocorticoids. (3) To learn the physiological effects of glucocorticoids. (4) To understand the anti-inflammatory mechanisms of glucocorticoids. (5) To understand the clinical uses of glucocorticoids. (6) To understand the structure-activity relationships of glucocorticoids. 2. 技能目标 | |||
| |||
1. The definition of glucocorticoids, chemical structure and structure-activity relationships of glucocorticoids. [15min] 2. Pharmacological effects of glucocorticoids. [20min] Anti-inflammatory effect, Immunosuppressive effects, Antishock effects, Other effects 3. Therapeutic applications. [25min] Replacement therapy, Severe infections or inflammations, Autoimmune and allergic diseases, Anti-shock therapy, Hematologic disease, Topical administration. 4. Adverse effects. [20min] 5. Pharmacological effects of mineralocorticoids. [10min] 6. Corticotropin and inhibitors. [10min] | |||
| |||
1.教学重点 (1)Pharmacological effects of glucocorticoids
2.教学难点 | |||
| |||
1.理论课堂教学 A. 多媒体教学: By using multimedia including PPT, cartoon, video in the teaching learning process, we convey vast information and provide many sources from which student can access the information. The Multimedia approach may improve the teaching learning process, provide the opportunity for the students to gain mastery of competencies and skills, and enable the students to get access to information in dynamic environment. B. 互动教学: What the developmental history of therapy for hypothyroidism? 2.实验教学: | |||
| |||
The treatment strategies for hyperadrenocorticism. | |||
| |||
1. To describe the pharmacological actions of corticosteroids. 2. What are the major adverse effects caused by long-term and overdose therapy of glucocorticoids? 3. Can the corticosteroids be used to treat peptic ulcers? Why? | |||
| |||
朱依谆主编. 药理学第八版, 北京, 人民卫生出版社, 2019 Oxford Textbook of Clinical Pharmacology and Drug Therapy David Grahame-Smith , Jeffrey Aronson. Edition: 3 Clinical Pharmacology Made Incredibly Easy! (Incredibly Easy! Series) Springhouse , 2008 Edition: 3Rev Ed. |
苏州大学医学部药学院授课教案
授课教师:张丽授课日期:2020.11.27
课程名称 | Pharmacology IV | 所属学科 | 药理学 |
教材名称 | Basic & Clinical Pharmacology, 14th edition | 授课年级 | 2018 药学 |
授课章节 | Chapter 41 Pancreatic Hormones & Antidiabetic Drug | 授课时间 | 50分钟 |
| |||
(1) To learn the pharmacological actions and therapeutic uses of insulin and antidiabetic drugs. (2) To learn the major adverse reactions of insulin and oral antidiabetic drugs. (4) To understand the definition and treatment of four types Diabetes. (5) To understand the principal types and duration of action of insulin preparations. (6) To understand the mechanisms of action of insulin and oral antidiabetic drugs. 2. 技能目标 | |||
| |||
1. Diabetes mellitus involves an inability to regulate plasma glucose within the normal range. Diabetes mellitus are characterized by insulin deficiency, and diabetes mellitus lead to hyperglycemia. [5 min] 2. Definition and treatment of four types Diabetes: Insulin-dependent diabetes, Non insulin-dependent diabetes, Gestational Diabetes Mellitus (GDM) and Other specific types. [5 min] 3. Pharmacological effects, therapeutic applications and adverse reactions of insulin. [10 min] 4. Principal types and duration of action of insulin preparations (classification and representative drugs). [5 min] 5. Classification of insulin delivery system: Regular injections, Portable pen injections, Continuous subcutaneous insulin infusion devices and Inhaled insulin. [5 min] 6. Classification and representative drugs of antidiabetic drugs. [5 min] 7. Pharmacological actions, adverse reactions, mechanism of action and clinical uses of antidiabetic drugs. [15 min] (1) Insulin Secretagogues: Sulfonylureas; Meglitinides (2) Insulin Sensitisers: Biguanides; Thiazolidinediones (3) Alpha-glucosidase inhibitors (4) Peptide analogs: Glucagon-like peptide analogs, DPP-4 inhibitors, Amylin analogues. | |||
| |||
1.教学重点 (1)Pharmacological actions, adverse reactions, mechanism of action and clinical uses of Sulfonylureas; (2)Pharmacological actions, adverse reactions, mechanism of action and clinical uses of Thiazolidinediones; 2.教学难点 | |||
| |||
1.理论课堂教学 A. 多媒体教学: By using multimedia including PPT, cartoon, video in the teaching learning process, we convey vast information and provide many sources from which student can access the information. The Multimedia approach may improve the teaching learning process, provide the opportunity for the students to gain mastery of competencies and skills, and enable the students to get access to information in dynamic environment. B. 互动教学: What the developmental history of therapy for hypothyroidism? 2.实验教学: | |||
| |||
The developmental history of treatment strategies for diabetes mellitus.. | |||
| |||
1. To describe the pharmacological actions of insulin. 2. What are the major adverse effects of insulin? 3. To state the classification of antidiabetic drugs. | |||
| |||
朱依谆主编. 药理学第八版, 北京, 人民卫生出版社, 2019 Oxford Textbook of Clinical Pharmacology and Drug Therapy David Grahame-Smith , Jeffrey Aronson. Edition: 3 Clinical Pharmacology Made Incredibly Easy! (Incredibly Easy! Series) Springhouse , 2008 Edition: 3Rev Ed. |
苏州大学医学部药学院授课教案
授课教师:张丽授课日期:2020.12.01
课程名称 | Pharmacology IV | 所属学科 | 药理学 |
教材名称 | Basic & Clinical Pharmacology, 14th edition | 授课年级 | 2018 药学 |
授课章节 | Chapter 62 Drugs Used in the Treatment of Gastrointestinal Diseases | 授课时间 | 100分钟 |
| |||
1.知识目标 1) To learn classification of drugs used in acid-peptic diseases. To learn feature and application principle of antacids. 2). To learn mechanism of action, clinical application assess and main adverse reaction of every variety of acid secretion inhibitors. 3). To understand pathogenesis and medication principle of peptic ulcer. 4) To understand pharmacological action and clinical application of mucosal protective agents and anti-Hp agents. 2. 技能(能力)目标 | |||
| |||
1. The pathogenesis of peptic ulcer is caused by the imbalance between aggressive and protective factors. [10 min] 2. Classification of drugs(agents that reduce intragastric acidity and agents that promote mucosal defense). [10 min] 3. Agents that reduce intragastric acidity (Antacids,H2 antagonists,Proton pump inhibitors (PPI)) mechanism of action, pharmacological effects, clinical uses and adverse reactions. [50 min] 4. Mucosal protective agents(sucralfate,prostaglandin analogs,colloidal bismuth compounds) mechanism of action, pharmacological effects, clinical uses and adverse reactions. [30 min] | |||
| |||
1.教学重点 (1)Agents that reduce intragastric acidity (Antacids,H2 antagonists,Proton pump inhibitors (PPI)) mechanism of action, pharmacological effects, clinical uses and adverse reactions. (2) Mucosal protective agents(sucralfate,prostaglandin analogs,colloidal bismuth compounds) mechanism of action, pharmacological effects, clinical uses and adverse reactions. 2.教学难点 | |||
| |||
1.理论课堂教学 A. 多媒体教学: By using multimedia including PPT, cartoon, video in the teaching learning process, we convey vast information and provide many sources from which student can access the information. The Multimedia approach may improve the teaching learning process, provide the opportunity for the students to gain mastery of competencies and skills, and enable the students to get access to information in dynamic environment. B. 互动教学: What is the developmental history of therapy for hypothyroidism? 2.实验教学: | |||
| |||
Marshall and Warren shared the Nobel Prize(2005) for Physiology or Medicine.. | |||
| |||
To describe the drugs used for gastroduodenal ulcer, their classification and mechanism. | |||
| |||
朱依谆主编. 药理学第八版, 北京, 人民卫生出版社, 2019 Oxford Textbook of Clinical Pharmacology and Drug Therapy David Grahame-Smith , Jeffrey Aronson. Edition: 3 Clinical Pharmacology Made Incredibly Easy! (Incredibly Easy! Series) Springhouse , 2008 Edition: 3Rev Ed. |
苏州大学医学部药学院授课教案
授课教师:张熠授课日期:2020.12.04
课程名称 | Pharmacology IV | 所属学科 | 药理学 |
教材名称 | Basic and Clinical Pharmacology, 14th | 授课年级 | 2018 |
授课章节 | Chapter 43 β-Lactam Antibiotics | 授课时间 | 150 min |
| |||
1.To learn the anti-microbial spectrum, mechanism of action, in vivo procedure and clinical application of benzylpenicillin. 2.To learn the traits of demi-synthesis penicillin; Mastering the antibacterial action and clinical application of Ampicillin and Amoxicillin. 3.To learn the product traits, representable drugs and clinical application of every generational cephalothin. 4.To Understand the traits of otherβ-Lactam and advantage and disadvantage . 5.To understand the outline of β-Lactam antibiotics. | |||
| |||
【Chemistry】10’ 1. The structure of the penicillins consists of a thiazolidine ring connected to a beta-lactam ring, which is attached to a side chain. 2. All penicillins are derived from 6-Amino-penicillanic acid. 3. The various penicillins differ in their side chain structure. 【Mechanism of action】20’ Penicillins inhibit bacterial growth by interfering with a specific step in bacterial cell wall synthesis. The cell wall is a rigid outer layer that completely surrounds the cytoplasmic membrane. It maintains the shape of the cell and prevents cell lysis that would occur as result of the high osmotic pressure within the cell compared to its external environment. 【Mechanism of bacterial resist to penicillins】20’ 1. The microorganism may be intrinsically resistant because of structural differences in the PBPs that are the targets of these drugs. 2. Other instances of bacterial resistance to the penicillins are caused by the inability of the agent to penetrate to its site of action. 3. Bacteria can destroy penicillins enzymatically. 【Spectrum of activity and clinical uses】 1. Penicillin G 15’ (1) This drug is highly effective against: a. gram-positive cocci: pneumococci, staphylococci, streptococci b. gram-negative cocci: meningococci, gonococci c. gram-positive bacilli: bacillus perfringens, bacillus diphtheriae d. spirochete: Treponema syphilis, Leptospira e. most anaerobe except bacteriodes fragilis (2) It is the drug of first choice for treating the infections of the above mentioned pathogens. (3) The simultaneous administration of the relevant antitoxin is often necessary for the treatment of diphtheria and tetanus. (4) The combination of an aminoglycoside is also necessary for bactericidal effects in enterococcal endocarditis. 2. Penicillase-resistant penicillins: oxacillin, cloxallin, dicloxallin, nafcillin They are the drugs of first choice for treating infections of the penicillase-productive aurococcus. 3. Broad-spectrum penicillins: ampicillin, amocillin (1) They are similar to penicillin G in the activity against gram-positive organisms but are weaker than the latter. (2) They are more satisfactory for the treatment of enterococci and streptococcus viridians. (3) They are similar to chloramphenicol in the activity against gram-negative organisms. (4) They are acid-resistant but are not penicillase-resistant. (5) Pseudomonas aeruginosa are fail to respond to these drugs. 4. Antipseudomonas penicillins: carbenicillin, ticarcillin, furbenicillin, piperacillin (1) They are similar to ampicillin in the activity against gram–positive organisms but more powerful and broader in the activity against gram-negative organisms than the latter. (2) They are not acid- resistant and penicillase-resistant. 【Untoward effects】20’ 1. Allergic reaction: (1) Antigenic determinant: Degradation products of penicillins (penicilloic acid, products of alkaline hydrolysis). (2) Manifestation: a. Typical anaphylactic shock (very rare, 0.05 ‰ recipients ). b. Typical serum sickness type reactions. c. A variety of skin rashes, oral lesions, fever, interstitial nephritis, eosinophilia, hemolytic anemia and other hematologic disturbances and vasculitis. (3) Prophylaxis a. Ask allergic history carefully . b. Must make skin test . c. The injection of these drugs is made up before it is injected. d. As a number of these drugs are replaced, the skin test must be done again. e. After every injection, all of patients must be observed, and the drugs for an emergency treatment are prepared at any time. (4) Treatment a. Desensitization: A method for reducing the effects of known allergen by injecting, over a period, gradually increasing doses of the allergen, until resistance is built up. Generally the patients allergic to penicillins can’t be treated with penicillins, but some individual cases (eg, a patient with endocarditis ) could be used desensitization therapy with gradually increasing dose of penicillin. Why can it be desensitized? This inhibitor bears a part or all of allergic reaction. It is not covalently with antibody, but prevents building a bridge between the molecules of antigen and antibody, therefore allergic reaction can do not occur. b. Adrenaline (epinephrine): being the first drug for the treatment of anaphylactic shock. Desamethasone and transfuse should be used when necessary 2. Other untoward effect: Gastrointestinal upset (orally administered preparations);Phlebitis, Injection site inflammatory reactions. Nephrotoxicity is very rare.Bone-marrow toxicity is uncommon. Superinfection results from alterations in intestinal flora.A higher incidence occurs with broad-spectrum penicillins. II. Cephalosporins 【Chemistry】10’ 1.The cephalosporins are derivatives of 7-aminocephalosporanic acid and are closely related in structure to penicillin. 2.They have a six-membered sulfur-containing ring adjoining a beta-lactam ring. 3.They are relatively stable in dilute acid and are highly resistant to penicillinase. 【Mechanism of action】10’ Cephalosporins inhibit bacterial cell wall synthesis in a manner similar to that of penicillin and are considered bactericidal. 【Spectrum of activity and Clinical uses】30’ 1. First-generation cephalosporins (cephalothin, cephalexin, cephazolin, cephradine) (1) They are similar to penicillin G in the antibiogram. Their activity is powerful against gram-positive organisms and is weaker against gram-negative. (2) They are not effective against pseudomonas. Comparatively, they are stable for beta-lactamase (penicillinase). (3) They are chiefly used in treating infection of the penicillinase-productive aurococcus. (4) They do not penetrate the central nervous system and can not be used to treat meningitis. 2. Second-generation cephalosporins (cefamandole, cefuroxime) (1) Their activity is more powerful against gram-negative organisms than the first generation cephalosporins but they are not effective against pseudomonas. A part of them are effective against anaerobe. (2) Their activity is weaker against gram-positive organisms than the first generation cephalo-sporins. (3) Their stability for beta-lactamases is high. (4) They are used in the infections with Escherichia coli, Klebsiella and the partial Proteus. (5) Cefuroxime is the only second-generation drug that crosses the blood-brain barrier well enough to be used for the treatment of meningitis, especially H influenzae meningitis , and sepsis. 3.Third-generation cephalosporins (cefofaxime cefoperazone, ceftriaxone, ceftazidime) (1) Their antibiogram are broader than second-generation cephalosporins. (2) They are effective against Pseudomonas and partial proteus. (3) They are effective against gram- positive organisms not as good as the first and second generation drugs. (4) Their stability for beta-lactamase is higher than the above two generation drugs. (5) They are chiefly used in the infections of the urethral or biliary tract with the drug-resistant strains and pseudomonas. (6) They are also used in some serious pneumonia ,sepsis and meningitis. 【Untoward effects】15’ Haemorrhagia, superinfection, allergy and gastrointestinal reactions and nephrotoxicity The first-generation cephalosporins have certain nephrotoxicity. The second-generation have slight nephrotoxicity. The third-generation have no nephrotoxicity | |||
| |||
| |||
| |||
多媒体教学 | |||
| |||
| |||
Describe the pharmacological effects of penicillin G What is the major mechanism of antibacterial action of β-Lactams? | |||
| |||
苏州大学医学部药学院授课教案
授课教师:张熠授课日期:2020.12.08
课程名称 | Pharmacology IV | 所属学科 | 药理学 |
教材名称 | Basic and Clinical Pharmacology, 14th | 授课年级 | 2018 |
授课章节 | Chapter 44. Tetracyclines | 授课时间 | 100 min |
| |||
| |||
| |||
I. Tetracyclines 15’ 【Mechanism of action】 They are primarily bacteriostatic, inhibiting protein synthesis. They bind to the 30S subunit of microbial ribosomes→block the attachment of charged aminoacyl-tRNA→prevent introduction of new amino acids into the nascent peptide chain 【Spectrum of activity】20’ 1. Tetracyclines are effective against G+and G-bacteria. 2. They are weaker than penicilins and cephalosporins against G+ organisms. 3. They are weaker than aminoglycosides and chloramphenicol against G- organisms. 4. They have the favourable effects on Rickettsiae, Mycoplasma, Chlamydiae and Spirochete. 5. They are effective against some protozoa. 【Clinical uses】25’ 1. The secondary drugs for treatment: The infectious diseases with G+and G- bacteria. 2. First choice for the treatment: The infection of Rickettsiae, Mycoplasma, Chlamydiae and Brucella. 【Untoward effects】15’ 1. Gastrointestinal reactions. 2. Superinfection: staphylococcal entero-colitis, interstitial candidiasis, pseudo- membranous colitis. 3. The effects on the bone and teeth of children: Yellow-brown discoloration of their teeth, depression of bone growth. 4. Serious hepatic damage. II. Chloramphenicols 【Mechanism of action】5’ It is mainly bacteriostatic, inhibiting protein synthesis . It attaches to the 50S subunit of the ribosome→inhibits peptidyl transferase→interferes with the binding of new amino acids to the nascent peptide chain. 【Antibiotic action】5’ Its effects on G- bacteria is better than on G+ bacteria , especially Salmonella typhi. 【Clinical uses】5’ 1. First choice for the treatment: typhoid and paratyphoid 2. Used only in serious infections with the sensitive bacteria. 【Untoward effects】10’ 1. Bone marrow depression: pancytopenia. 2. Gray-baby syndrome: cynosis, respiratory irregularities, vomiting, abdominal distention, vasomotor collapse, loose green stools , and an ashen gray color. 3. Gastrointestinal reaction. 4. Superinfection. 5. Allergy | |||
| |||
| |||
| |||
多媒体教学 | |||
| |||
| |||
What are differences of antibacterial spectra between chloramphenicol and tetracyclines | |||
| |||
苏州大学医学部药学院授课教案
授课教师:张熠授课日期:2020.12.15
课程名称 | Pharmacology IV | 所属学科 | 药理学 |
教材名称 | Basic and Clinical Pharmacology, 14th | 授课年级 | 2018 |
授课章节 | Chapter 45. Aminoglycosides | 授课时间 | 100 min |
| |||
1.To learn the action, mechanism, clinical application and adverse reaction of aminoglycosides. 2.To learn the clinical application of aminoglycosides frequently used such as gentamicin, tobramycin and amikacin 3.To understand the traits of action of colistin | |||
| |||
Introduction】15’ 1. Aminoglycosides are a group of bactericidal antibiotics. 2. They are obtained from various Streptomyces species 3. They share chemical, antimicrobial, pharmacological, and toxic characteristics. 4. Aminoglycosides include: (1) Gentamicin, streptomycin, tobramycin, and amikacin: are the most widely used aminoglycosides at present (2) kanamycin, neomycin (3) sisomicin, netilmicin, and others. 【General Properties of Aminoglycosides】25’ (1) Aminoglycosides consist of amino sugars joined in glycoside linkage to a hexose nucleus. (2) They are water-soluble, stable in solution, and more active at alkaline than at acid pH. Sodium bicarbonate increase the activity (3) Aminoglycosides frequently exhibit synergism with beta lactams. (4) At high concentration, aminoglycosides may complex with beta-lactam drugs, resulting in loss of activity, and they should not be mixed together for administration (in buttock, i.m.) 2. Pharmacokinetics (1) Aminoglycosides are hardly absorbed orally (2) They are well absorbed intramuscularly, giving peak concentrations in blood within 30~90 min. (3) They do not enter cells readily and no significant metabolism (4) Aminoglycosides are cleared by thekidney (5) Normal t 1/2 is 2~3 h,increasing to 24~48 h inpatients with significant impairment of renal function. Their monitoring of plasma levels is an important requirement for safe and effective dosage selection. 3. Action and its mechanism 25’ (a) Antibacterial activity of aminoglycosides is primarily against aerobic gram-negative bacilli (b) Their action against most gram-positive bacteria is limited (c) In combination with a cell-wall-active agent, such as penicillin, and aminoglycosides are more active against enterococci and streptococci (2) Mechanism of action Aminoglycosidesbinds to specific 30S-subunit ribosomal proteins.Protein synthesis is inhibited by them in at least three ways (see Fig 36-1 ): (a) They interfere with the “initiation complex of peptide formation (b) They induce misreading of mRNA® causes incorporation of incorrect amino acids into peptide ® resulting in a non-functional or toxic protein. 4. Resistance and its mechanisms 10’ (1) Microorganism produces a transferase enzyme or enzyme that inactivate the aminoglycoside by adenylylation, acetylation or phosphorylation (2) Impaired entry of drugs into cells (3) Receptor protein on 30S ribosomal subunit may be deleted or altered as a result of a mutation. 5. Adverse effects 15’ A. Ototoxicity:It is largely irreversible and results from progressive destruction of vestibule or cochlear sensory cells, which are highly sensitive to damage by aminoglycosides (1) Cochlear damage: resulting in tinnitus and hearing loss; amikacin, kanamycin, and neomycin primarily affect auditory function (2) Vestibule damage: vertigo, ataxia, and loss of balance. Streptomycin and gentamicin produce predominantly vestibule damage It is recommended that patients is monitored carefully for ototoxicity, when receiving high doseandprolonged course of aminoglycosides, since initial symptoms may be reversible; however, deafness may occur several weeks after therapy is discontinued . B. Nephrotoxicity (1) Drugs can alter structure and function of renal proximal tubular cells. (2) There are mild proteinuria, appearance of hyaline and granular casts, and mild rise of plasmacreatinine (3) These effects usually are reversible. Neomycin, tobramycin, and gentamicin are the most nephrotoxic. (4) Concurrent use with loop diuretics (e.g., furosemide, ethacrynic acid ) or other nephrotoxic antimicrobial agents (e.g.vancomycin or amphotericin)can potentiate nephrotoxicity and should be avoided if possible (5) Monitoring drug concentrations in plasma is useful, particularly during prolonged andhigh-dose therapy C. Neuromuscular blockade: (1) Drugs can produce a neuromuscular blockade, resulting in respiratory paralysis. (2) Most episodes have occurred in association with anesthesia or the administration of other neuromuscular blocking agents. (3) This paralysis is usually reversible by calcium gluconate or neostigmine. D. Hypersensitivity: It occurs infrequently. allergic shock, anaphylaxis and rash are unusual 【Clinical uses】10 (5) Normal t 1/2 is 2~3 h,increasing to 24~48 h inpatients with significant impairment of renal function. Their monitoring of plasma levels is an important requirement for safe and effective dosage selection 3. Action and its mechanism (a) Antibacterial activity of aminoglycosides is primarily against aerobic gram-negative bacilli (b) Their action against most gram-positive bacteria is limited (c) In combination with a cell-wall-active agent, such as penicillin, and aminoglycosides are more active against enterococci and streptococci (2) Mechanism of action Aminoglycosidesbinds to specific 30S-subunit ribosomal proteins.Protein synthesis is inhibited by them in at least three ways (see Fig 36-1 ): (a) They interfere with the “initiation complex of peptide formation (b) They induce misreading of mRNA® causes incorporation of incorrect amino acids into peptide ® resulting in a non-functional or toxic protein. 4. Resistance and its mechanisms (1) Microorganism produces a transferase enzyme or enzyme that inactivate the aminoglycoside by adenylylation, acetylation or phosphorylation (2) Impaired entry of drugs into cells (3) Receptor protein on 30S ribosomal subunit may be deleted or altered as a result of a mutation. 5. Adverse effects A. Ototoxicity:It is largely irreversible and results from progressive destruction of vestibule or cochlear sensory cells, which are highly sensitive to damage by aminoglycosides (1) Cochlear damage: resulting in tinnitus and hearing loss; amikacin, kanamycin, and neomycin primarily affect auditory function (2) Vestibule damage: vertigo, ataxia, and loss of balance. Streptomycin and gentamicin produce predominantly vestibule damage It is recommended that patients is monitored carefully for ototoxicity, when receiving high doseandprolonged course of aminoglycosides, since initial symptoms may be reversible; however, deafness may occur several weeks after therapy is discontinued . B. Nephrotoxicity (1) Drugs can alter structure and function of renal proximal tubular cells. (2) There are mild proteinuria, appearance of hyaline and granular casts, and mild rise of plasmacreatinine (3) These effects usually are reversible. Neomycin, tobramycin, and gentamicin are the most nephrotoxic. (4) Concurrent use with loop diuretics (e.g., furosemide, ethacrynic acid ) or other nephrotoxic antimicrobial agents (e.g.vancomycin or amphotericin)can potentiate nephrotoxicity and should be avoided if possible (5) Monitoring drug concentrations in plasma is useful, particularly during prolonged andhigh-dose therapy C. Neuromuscular blockade: (1) Drugs can produce a neuromuscular blockade, resulting in respiratory paralysis. (2) Most episodes have occurred in association with anesthesia or the administration of other neuromuscular blocking agents. (3) This paralysis is usually reversible by calcium gluconate or neostigmine. D. Hypersensitivity: It occurs infrequently. allergic shock, anaphylaxis and rash are unusual 【Clinical uses】 | |||
| |||
How to reduce the occurrence of adverse effects when using aminoglycosides?
| |||
| |||
多媒体教学 | |||
| |||
| |||
What are the common properties of aminoglycosides? Describe the clinical application of Gentamicin and amikacin | |||
| |||
苏州大学医学部药学院授课教案
授课教师:贾佳授课日期:2020.12.18
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic and Clinical Pharmacology, 14th | 授课年级 | 2018药学 |
授课章节 | Chapter 46 Sulfonamides and quinolones | 授课时间 | 100分钟 |
| |||
(1) To learn the antimicrobial activity, clinical uses and adverse reactions of fluoroquinolones.(2) To learn the antimicrobial activity and mechanism of sulfonamides.(3) To learn the mechanism and significant of combinational use of sulfonamides and trimethoprim. (4) To understand other synthetic antimicrobial drugs.
| |||
| |||
1. Classification of synthetic antimicrobial agents: antifolate drugs (Sulfonamides &Trimethoprim) and DNA gyrase inhibitors (Fluoroquinolones). [10 min] 2. Sulfonamides: chemistry, antimicrobial activity, mechanism of action, clinical uses, and adverse reactions.[30 min] 3. Trimethoprim and Sulfamethoxazole mixtures (TMP-SMZ): mechanism of action, mechanism of resistance, clinical uses and adverse reactions. [30 min] 4. Quinolones: classification, pharmacological effects, mechanism of action, clinical uses and adverse reactions. [30 min] | |||
| |||
(1)The synergic mechanisms of combined use of sulfonamides and trimethoprim | |||
| |||
A. 多媒体教学: B. 互动教学: Question-raising
| |||
| |||
| |||
| |||
The history and development of synthetic antimicrobial drugs. |
苏州大学医学部药学院授课教案
授课教师:贾佳授课日期:2020.12.22
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic and Clinical Pharmacology, 14th | 授课年级 | 2018药学 |
授课章节 | Chapter 47 Antimycobacterial drugs | 授课时间 | 50分钟 |
| |||
1. 知识目标: (1) To learn the pharmacological actions, clinical application and adverse reactions of the first-line antituberculous drugs (isoniazid, rifampin, pyrazinamide, ethambutol & streptomycin). (2) To understand the principles of antituberculosis chemotherapy. (3) To understand the pharmacological actions of the second-line antituberculous drugs. 2. 技能(能力)目标: (1) To describe the characteristics of INH & Rifampin. (2) To describe the principles of application when using antituberculous drugs. | |||
| |||
1. Introduction of tuburculosis (TB). [5 min] 2. Classification of drugs for treatment of TB: first-line and second-line agents. [5 min] 3. Pharmacological actions, mechanism of action, clinical uses and adverse reactions of first-line antituberculous drugs. [30 min] 4. Principles of antituberculosis chemotherapy. [10 min] | |||
| |||
(1) The pharmacological actions, clinical application and adverse reactions of the first-line antituberculous drugs (2) The principles of antituberculosis chemotherapy
| |||
| |||
A. 多媒体教学: Clinical cases B. 互动教学: Question-raising
| |||
| |||
| |||
1. What are the principles of application when using antituberculous drugs? 2. What are the first-line and second-line antituberculous drugs? 3. What are the characteristics of INH & Rifampin? | |||
|
苏州大学医学部药学院授课教案
授课教师:贾佳授课日期:2020.12.22
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic and Clinical Pharmacology, 14th | 授课年级 | 2018药学 |
授课章节 | Chapter 48 Antifungal drugs | 授课时间 | 50分钟 |
| |||
1. 知识目标: (1) To learn the therapeutic applications of amphotericin B, glucytosine, and griseofulvin (2) To understand the classification of antifungal drugs. (3) To understand the action sites of antifungal agents 2. 技能(能力)目标: (1) To describe the pharmacological actions and thetherapeutic applications of amphotericin B and azole drugs. (2) To describe the main adverse reactions of antifungal drugs. | |||
| |||
1. Introduction of the main fungal infections. [5 min] 2. Classification of antifugal drugs. [5 min] 3. The action sites of antifungal agents. [10 min] 3. Pharmacological actions, mechanism of action, clinical uses and adverse reactions of amphotericin B and other antifungal drugs. [30 min] | |||
| |||
The pharmacological actions, clinical application and adverse reactions of antifungal drugs.
The action sites of antifungal agents | |||
| |||
A. 多媒体教学: Clinical cases B. 互动教学: Question-raising
| |||
| |||
| |||
1. Describe the categories of antifungal drugs. 2. What are the main action sites of antifungal agents? 3. Describe the characteristics of some common antifungal drugs. | |||
|
苏州大学医学部药学院授课教案
授课教师:贾佳授课日期:2020.12.25
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic and Clinical Pharmacology, 14th | 授课年级 | 2018药学 |
授课章节 | Chapter 49 Antiviral drugs | 授课时间 | 50分钟 |
| |||
1. 知识目标: (1) To learn the therapeutic applications of antiviral drugs. (2) To understand the mechanism of action of antiviral drugs. (3) To understand the classification of antiviral drugs. 2. 技能(能力)目标: (1) To describe the pharmacological actions andthe therapeutic applications of antiherpes agentsand antiretroviral agents. (2) To describe the classification of antiviral drugs. | |||
| |||
1. The steps for viral replication. [5 min] 2. Classification of antiviral drugs. [5 min] 3. The major action sites of antiviral agents. [10 min] 4. Pharmacological actions, mechanism of action, clinical uses and adverse reactions of antiherpes agents, antiretroviral agents and other antiviral drugs. [30 min] | |||
| |||
The pharmacological actions, clinical application and adverse reactions of acyclovir, zidovudine and other antiviral agents.
The classification of antifungal agents | |||
| |||
A. 多媒体教学: Clinical cases B. 互动教学: Question-raising
| |||
| |||
| |||
1. Describe the classification of antiviral agents. 2. Describe the main action sites of antiviral agents? 3. Describe the characteristics of some commonantiviral drugs. | |||
|
苏州大学医学部药学院授课教案
授课教师:贾佳授课日期:2020.12.25
课程名称 | Pharmacology IV | 所属学科 | 药学 |
教材名称 | Basic and Clinical Pharmacology, 14th | 授课年级 | 2018药学 |
授课章节 | Chapter 51 Clinical Use of Antimicrobial Agents | 授课时间 | 50分钟 |
| |||
1. 知识目标: (1) To learn the clinical uses of antimicrobial agents. (2) To learn the mechanisms of bacterial resistance. (3) To understand antimicrobial drug combinations. (4) To understand the antimicrobial pharmacodynamics and pharmacokinetic consideratons. 2.技能(能力)目标: (1) To describe the mechanisms of bacterial resistance. | |||
| |||
1. Misuse of antibiotics. [5 min] 2. Mechanisms of bacterial resistance. [10 min] 3. Empirical antimicrobial therapy. [10 min] 4. Antimicrobial therapy of infections with known etiology. [15 min] 5. Antimicrobial drug combinations. [10 min] | |||
| |||
(1) The clinical uses of antimicrobial agents (2) The mechanisms of bacterial resistance (3) Antimicrobial drug combinations
(1) The rational uses of antimicrobial agents | |||
| |||
A. 多媒体教学: Clinical cases B. 互动教学: Question-raising
| |||
| |||
| |||
| |||
|
苏州大学医学部药学院授课教案
授课教师:张熠授课日期:2020.12.29
课程名称 | Pharmacology IV | 所属学科 | 药理学 |
教材名称 | 《Basic and Clinical Pharmacology》14th | 授课年级 | 2018 |
授课章节 | Chapter 54. Cancer Chemotherapy | 授课时间 | 100 min |
| |||
(1) Cancer Biology: What is Cancer? What are the difference between normal and cancer cells? How does cancer take place?(2) Principle and strategy for cancer therapy.(3) Anti-Cancer drugs and their Pharmacology.(4) Chemotherapy: Pros and Cons. | |||
| |||
1. Distinguishable Features of Cancer Cells. [15 min] The origin of a tumor is from the existing cells or tissues of the body. •The tumor grows following its own laws and is not regulated by the existing laws of biology. ---(Uncontrollably) •The rate of growth and multiplication > the ordinary healthy cells--(rapid growth) •Anaplasia: Generally, cells divide from their embryonic cells into smaller independent entities. In case of cancer cells, they have the ability to form the undifferentiated cells back from being differentiated. (undifferentiated) •Performance does not like the tasks carried out by healthy cells. (mal-functional) •Loss of the contact from the tumor from which they originate and can spread to fresh locations of the body to grow and survive independently. (--Invasive and metastasis) •Genetic instability 2. Causes of Cancer. [10 min] •Sex: male>women •Age: most cancers in people> 50 YO •Race •Genetic predisposition •Environment—living and working (Chemicals, Viruses) •Lifestyle—smoking, alcoholism, preserved food, BBQ 3. Cancer Therapeutic Modalities: Surgery, Chemotherapy, Radiation therapy, Palliative care. [10 min] 4. Cell cycle and anti-cancer drugs. [10 min] 5. Resistance to anti-Cancer drugs. [10 min] •Resistance to cancer chemotherapeutic drugs is a major limitation to treatment. •Primary resistance occurs when some inherent characteristic of the cancer cells prevents the drugs from working. •Acquired resistance occurs when cancer cells become resistant during treatment. •Multidrug resistance is particularly problematic; this occurs when tumor cells become cross-resistant to a wide range of chemically dissimilar agents after exposure to a Single (typically natural product) drug. 6. Basic pharmacology of cancer chemotherapeutic drugs. [10 min] 7. Classification of Anti-Cancer Drugs. [15 min] Alkylating Agents: Cyclophosphamide, Melphelan, Nitrosourea,Platinum analogs: Cisplatin, Carboplatin Antimetabolites: Cytarabine, Fludarabine, Methotrexate Plant alkaloids: Camptothecins, Etoposide, Paclitaxel, Vinblastine Antitumor antibiotics: Bleomycin, Doxorubicin, Mitomycin Hormonal Agents: Flutamide, Leuprolide,Tamoxifen, Differential Inducer: Arsenic trioxide, Retinoic acid derivatives Gene targeted drugs: Cetuximab, Dasatinib, Gefitinib, Imatinib Immunomodulators: including cytokines and growth factors Antiangiogenesis drugs: sorafenib, sunitinib, pazopanib 8. Molecularly Targeted Anti-cancer Drugs. [10min] 9. Chemotherapy: Pros and Cons. [10min] A broad spectrum : almost all kinds of cancers from all organs, including Brain, blood, breast, colon, stomach, lung, and prostate. Killing of cancer cells that rapidly grow, or specific genetic presented cancers. More effective when used in combination with other drugs or other methods, such as surgery or radiotherapy. No anticancer drugs are perfect that kill cancer cells only. Most adverse effects are: (1) Myelosuppression—anemia, hemorrhage, prone to infection (2) Somatitis (3) Alopecia (4) Gastrointestinal effects | |||
| |||
1.What are the differences between normal cells and cancer cells? 2. What is the Kill-log curve? How does it guide the cancer therapy? 3. What is the importance of the cell cycle in selecting and developing anti-cancer drugs? 4. How do cancer cells develop resistance to anticancer drugs? How to avoid chemical resistance in anti-cancer therapy? 5. How many classifications are there in anti-cancer drugs? 6. What are the mechanisms of action of the prototype of each class?
| |||
| |||
多媒体教学 | |||
| |||
| |||
1. Is there no toxic effects for molecularly targeted cancer drugs? 2. Why is it suggestive to use combined therapy? Give an example of such combined therapy. | |||
| |||